Skip to main content
Innate Pharma logo

Innate Pharma — Investor Relations & Filings

Ticker · IPH ISIN · FR0010331421 LEI · 9695002Y8420ZB8HJE29 PA Manufacturing
Filings indexed 1,403 across all filing types
Latest filing 2022-04-05 Foreign Filer Report
Country FR France
Listing PA IPH

About Innate Pharma

http://www.innate-pharma.com/

Innate Pharma is a clinical-stage, oncology-focused biotechnology company that develops immunotherapies for cancer patients. The company's scientific approach is centered on leveraging the innate immune system, particularly Natural Killer (NK) cells, to create novel treatments. Its innovative pipeline is composed of antibody-based therapeutics, including first-in-class monoclonal antibodies, antibody-drug conjugates (ADCs), and multi-specific NK cell engagers based on its proprietary ANKET® platform. Key clinical programs include lacutamab (anti-KIR3DL2), monalizumab (anti-NKG2A) in partnership with AstraZeneca, and a portfolio of NK cell engagers targeting various hematological malignancies and solid tumors.

Recent filings

Filing Released Lang Actions
INNATE PHARMA S.A. 6-K
Foreign Filer Report
2022-04-05 English
Rapports financiers et d'audit annuels / Rapport financier annuel
Audit Report / Information Classification · 1% confidence The document is a press release titled "INNATE PHARMA PUBLIE SON DOCUMENT D'ENREGISTREMENT UNIVERSEL 2021 ET SON RAPPORT ANNUEL 2021 SUR « FORM 20-F »". It explicitly states that the Universal Registration Document (Document d'enregistrement universel) and the Form 20-F Annual Report for 2021 have been filed with the AMF and SEC, respectively. The Form 20-F is the standard SEC filing for foreign private issuers that serves as their annual report, equivalent to a 10-K for domestic issuers. Since this document is an announcement *about* the filing/publication of the annual report (Form 20-F/Universal Registration Document) rather than the full report itself, and given its short length and announcement nature, it fits the description of a Report Publication Announcement (RPA). However, the 10-K code specifically covers the 'Official yearly report covering company activity and full financial performance.' Since the document explicitly mentions the filing of the 'rapport financier annuel 2021' and the 'Form 20-F' (which is the annual report), and the document length is substantial enough (5727 chars) to be more than just a brief notice, classifying it as the report itself (10-K) is often preferred when the core subject is the release of the annual filing, especially when the filing is explicitly named. Given the dual nature (announcement of the 20-F/Annual Report), and the fact that the 10-K definition covers the 'Official yearly report', I will lean towards 10-K as the primary subject matter being announced, but RPA is a strong secondary candidate based on the 'MENU VS MEAL' rule. Since the document is announcing the availability of the *full* annual report (Form 20-F), and the 10-K code is the closest match for the content being released (Annual Report), I will select 10-K, acknowledging the announcement context. FY 2021
2022-04-05 French
Annual financial and audit reports / Annual financial report
Report Publication Announcement Classification · 1% confidence The document is a press release announcing the filing of the company's 2021 Universal Registration Document and 2021 Annual Report on Form 20-F. It provides links to where these reports can be accessed rather than containing the financial reports themselves. Per the 'Menu vs Meal' rule, this is a Report Publication Announcement (RPA). FY 2021
2022-04-05 English
20-F
Annual Report FY 2021
2022-04-04 English
Document d'enregistrement universel 2021
Annual Report (ESEF) Classification · 1% confidence FY 2021
2022-04-04 French
Document d'enregistrement universel 2021
Annual Report (ESEF) Classification · 0% confidence FY 2021
2022-04-04 French

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.